5-HT1A C-1019G (rs6295) Predicts Aripiprazole Treatment Response Specifically for Cognitive and Depressive Symptoms in Schizophrenia

J Clin Psychopharmacol. 2017 Feb;37(1):114-118. doi: 10.1097/JCP.0000000000000628.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / pharmacology*
  • Aripiprazole / administration & dosage
  • Aripiprazole / pharmacology*
  • Cognitive Dysfunction / drug therapy*
  • Cognitive Dysfunction / etiology
  • Depression / drug therapy*
  • Depression / etiology
  • Depression / genetics
  • Female
  • Humans
  • Male
  • Receptor, Serotonin, 5-HT1A / genetics*
  • Schizophrenia / complications
  • Schizophrenia / drug therapy*
  • Schizophrenia / genetics
  • Serotonin 5-HT1 Receptor Agonists / administration & dosage
  • Serotonin 5-HT1 Receptor Agonists / pharmacology*
  • Young Adult

Substances

  • Antipsychotic Agents
  • HTR1A protein, human
  • Serotonin 5-HT1 Receptor Agonists
  • Receptor, Serotonin, 5-HT1A
  • Aripiprazole